Paid Clinical Trials for Estrogen Receptor-Positive Breast Carcinoma

Login to your account

Reset Password

Please Enter Username or Email

Create a free account

I'm a Participant
I'm an Organization

Showing all 3 results

Testing Low Dose Tamoxifen for Invasive Breast Cancer, the (LoTam) Trial

by CTG

in HER2-Negative Breast Carcinoma, Anatomic Stage IIA Breast Cancer AJCC V8, Anatomic Stage 0 Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, Anatomic Stage 1 Breast Cancer AJCC v8

Other

Alaska

Deadline:

11/30/2031

Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer

by CTG

in Metastatic Breast Carcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma

Other

California

Deadline:

10/29/2026

Turkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing Surgery

by CTG

in HER2-Negative Breast Carcinoma, Estrogen Receptor-Positive Breast Carcinoma

Other

Arizona

Deadline:

04/30/2027